SEARCH

SEARCH BY CITATION

References

  • 1
    Wiedmeyer CE, Johnson PJ, Cohn LA, et al. Evaluation of a continuous glucose monitoring system for use in dogs, cats, and horses. J Am Vet Med Assoc 2003;223:987992.
  • 2
    Davison LJ, Slater LA, Herrtage ME, et al. Evaluation of a continuous glucose monitoring system in diabetic dogs. J Small Anim Pract 2003;44:435442.
  • 3
    Rebrin K, Steil GM, Van Antwerp WP, et al. Subcutaneous glucose predicts plasma glucose independent of insulin: Implications for continuous monitoring. Am J Physiol 1999;277:E561E571.
  • 4
    Ristic JM, Herrtage ME, Walti-Lauger SM, et al. Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus. J Feline Med Surg 2005;7:153162.
  • 5
    Abel P, Muller A, Fischer U. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell. Biomed Biochim Acta 1984;43:577584.
  • 6
    Bindra DS, Zhang Y, Wilson GS, et al. Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. Anal Chem 1991;63:16921696.
  • 7
    Poitout V, Moatti-Sirat D, Reach G. Development of a glucose sensor for glucose monitoring in man: The disposable implant concept. Clin Mater 1994;15:241246.
  • 8
    Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther 2000;2:461472.
  • 9
    Steil GM, Rebrin K, Hariri F, et al. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia 2005;48:18331840.
  • 10
    Steil GM, Rebrin K, Mittelman SD, et al. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes 1998;47:714720.
  • 11
    Sternberg F, Meyerhoff C, Mennel FJ, et al. Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care 1995;18:12661269.
  • 12
    Wiedmeyer CE, Johnson PJ, Cohn LA, et al. Evaluation of a continuous glucose monitoring system for use in veterinary medicine. Diabetes Technol Ther 2005;7:885895.
  • 13
    DeClue AE, Cohn LA, Kerl ME, et al. Use of continuous blood glucose monitoring for animals with diabetes mellitus. J Am Anim Hosp Assoc 2004;40:171173.
  • 14
    Cohn LA, McCaw DL, Tate DJ, et al. Assessment of five portable blood glucose meters, a point-of-care analyzer, and color test strips for measuring blood glucose concentration in dogs. J Am Vet Med Assoc 2000;216:198202.
  • 15
    Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:4956.
  • 16
    Jamali R, Ludvigsson J, Mohseni S. Continuous monitoring of the subcutaneous glucose level in freely moving normal and diabetic rats and in humans with type 1 diabetes. Diabetes Technol Ther 2002;4:305312.
  • 17
    Casella M, Wess G, Hassig M, et al. Home monitoring of blood glucose concentration by owners of diabetic dogs. J Small Anim Pract 2003;44:298305.
  • 18
    Casella M, Wess G, Reusch CE. Measurement of capillary blood glucose concentrations by pet owners: A new tool in the management of diabetes mellitus. J Am Anim Hosp Assoc 2002;38:239245.
  • 19
    Rusavy Z, Sramek V, Lacigova S, et al. Influence of insulin on glucose metabolism and energy expenditure in septic patients. Crit Care 2004;8:R213R220.
  • 20
    Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004;30:748756.
  • 21
    Brady CA, Hughes D, Drobatz KJ. Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure. J Vet Emergency Crit Care 2004;14:177182.